Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 1 to 20 of 367

Tests names and labsConditionsGenes, analytes, and microbesMethods

Tempus xT

Tempus Labs, Inc.
United States
2647
  • I Microsatellite instability testing (MSI)
  • C Sequence analysis of the entire coding region

Multigene Myeloid Panel

UCSF Molecular Diagnostics Laboratory University of California, San Francisco
United States
152
  • X Mutation scanning of select exons

Comprehensive HemeComplete Profile + Heme Fusion + CALR PCR + FLT3 PCR

PathGroup
United States
16160
  • T Targeted variant analysis

UCSF Molecular Diagnostics Laboratory

UCSF Molecular Diagnostics Laboratory University of California, San Francisco
United States
452
  • C Sequence analysis of the entire coding region

MayoComplete Solid Tumor Panel

Mayo Clinic Laboratories Mayo Clinic
United States
1476
  • I Microsatellite instability testing (MSI)
  • R RNA analysis
  • C Sequence analysis of the entire coding region

JAX SOMASEQ

The Jackson Laboratory for Genomic Medicine
United States
1517
  • D Deletion/duplication analysis
  • I Microsatellite instability testing (MSI)
  • R RNA analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Myeloid NextGen Sequencing Assay with Calreticulin Exon 9 Mutation

PathGroup
United States
1665
  • T Targeted variant analysis

Myeloid NextGen Sequencing Assay

PathGroup
United States
1665
  • T Targeted variant analysis

Myeloid NextGen Sequencing Assay with FLT3 ITD and TKD Analysis

PathGroup
United States
1665
  • T Targeted variant analysis

Comprehensive Myeloid Profile + CALR PCR + FLT3 PCR

PathGroup
United States
1665
  • T Targeted variant analysis

Comprehensive HemeComplete Profile with IGH Somatic Hypermutation

PathGroup
United States
13161
  • E Sequence analysis of select exons
  • T Targeted variant analysis

HemeComplete NextGen Sequencing Assay with Calreticulin Exon 9 Mutation, FLT3 ITD and TKD Analysis and T-Cell Clonality Analysis

PathGroup
United States
23160
  • T Targeted variant analysis

HemeComplete NextGen Sequencing Assay with Calreticulin Exon 9 Mutation, FLT3 ITD and TKD Analysis and JAK2 V617F Quant

PathGroup
United States
18160
  • T Targeted variant analysis

Comprehensive HemeComplete Profile + CALR PCR + FLT3 PCR + BCR/ABL1 IS

PathGroup
United States
17160
  • T Targeted variant analysis

Comprehensive HemeComplete Profile + CALR PCR + FLT3 PCR + BCR/ABL1

PathGroup
United States
17160
  • T Targeted variant analysis

Comprehensive HemeComplete Profile + CALR PCR + FLT3 PCR

PathGroup
United States
16160
  • T Targeted variant analysis

ProvSeq 523

Providence St. Joseph Health Molecular Genomics Laboratory Providence St Joseph Health
United States
1523
  • C Sequence analysis of the entire coding region

Comprehensive Hematologic Cancer Panel

Genomic Diagnostic Laboratory, Division of Genomic Diagnostics Children's Hospital of Philadelphia
United States
2215
  • D Deletion/duplication analysis
  • R RNA analysis
  • C Sequence analysis of the entire coding region

Myeloid Malignancies Mutation and Copy Number Variation Panel by Next Generation Sequencing

ARUP Laboratories, Molecular Oncology ARUP Laboratories
United States
665
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

OnkoSight Advanced NGS Comprehensive Myeloid Panel

BioReference Health
United States
175
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 367

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.